News and Announcements
Capital Raising 3.0: Unveiling the Future of Venture Investment
- Published May 31, 2023 11:00PM UTC
- Publisher Wholesale Investor
- Categories Capital Insights, Capital Raising Tips
Discover the future of venture investment with Capital Raising 3.0. Join us in this engaging presentation as we delve into the history of capital raising, explore the key focus areas of the innovative Capital Raising 3.0 approach, and highlight how Wholesale Investor leverages its experience in funding companies.
Throughout the years, the landscape of capital raising has evolved, and Capital Raising 3.0 represents the next chapter in this dynamic journey. Gain valuable insights into the changing dynamics and emerging trends that shape the future of venture investment.
Our presentation explores the core principles and strategies of Capital Raising 3.0, providing you with a comprehensive understanding of the key elements that drive success in modern capital raising efforts. We share real-world examples and lessons learned from the companies that Wholesale Investor has supported, offering practical knowledge and actionable advice for entrepreneurs and investors alike.
Don’t miss this opportunity to stay ahead of the curve and navigate the ever-changing world of venture investment. Join us for an informative and thought-provoking session on Capital Raising 3.0 and unlock the potential for growth and success in your capital raising endeavors.
Capital Raising Tips
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
